Publicaciones en las que colabora con MIKEL GARCÍA PUGA (12)

2022

  1. Chaperone-Mediated Autophagy Controls Proteomic and Transcriptomic Pathways to Maintain Glioma Stem Cell Activity

    Cancer Research, Vol. 82, Núm. 7, pp. 1283-1297

  2. Senescence plays a role in myotonic dystrophy type 1

    JCI insight, Vol. 7, Núm. 19

  3. Targeting Myotonic Dystrophy Type 1 with Metformin

    International Journal of Molecular Sciences, Vol. 23, Núm. 5

2020

  1. Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study

    Annals of Clinical and Translational Neurology, Vol. 7, Núm. 1, pp. 126-131

  2. Myotonic Dystrophy type 1 cells display impaired metabolism and mitochondrial dysfunction that are reversed by metformin

    Aging, Vol. 12, Núm. 7, pp. 6260-6275

  3. SOX9 promotes tumor progression through the axis BMI1-p21CIP

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Therapeutic relevance of SOX9 stem cell factor in gastric cancer

    Expert Opinion on Therapeutic Targets, Vol. 23, Núm. 2, pp. 143-152

2018

  1. Towards precision medicine: linking genetic and cellular heterogeneity in gastric cancer

    Therapeutic Advances in Medical Oncology, Vol. 10

2016

  1. Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation

    Neurology, Vol. 87, Núm. 12, pp. 1250-1257

  2. Paradoxical role of SOX2 in gastric cancer

    American Journal of Cancer Research, Vol. 6, Núm. 4, pp. 701-713

  3. SOX9 elevation acts with canonical WNT signaling to drive gastric cancer progression

    Cancer Research, Vol. 76, Núm. 22, pp. 6735-6746

2015

  1. Muscle wasting in myotonic dystrophies: A model of premature aging

    Frontiers in Aging Neuroscience, Vol. 7, Núm. JUN